Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0H3NO
|
|||
Drug Name |
PMID27744724-Compound-4
|
|||
Drug Type |
Small molecular drug
|
|||
Company |
ABBOTT LABORATORIES
|
|||
Structure |
Download2D MOL |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Induced myeloid leukemia cell differentiation protein Mcl-1 (MCL1) | Target Info | Inhibitor | [1] |
Target's Patent Info | Induced myeloid leukemia cell differentiation protein Mcl-1 (MCL1) | Target's Patent Info | [1] | |
KEGG Pathway | PI3K-Akt signaling pathway | |||
MicroRNAs in cancer | ||||
NetPath Pathway | TCR Signaling Pathway | |||
Panther Pathway | Apoptosis signaling pathway | |||
CCKR signaling map ST | ||||
Pathway Interaction Database | E2F transcription factor network | |||
Direct p53 effectors | ||||
IL6-mediated signaling events | ||||
HIF-1-alpha transcription factor network | ||||
WikiPathways | Apoptosis | |||
miR-targeted genes in muscle cell - TarBase | ||||
miR-targeted genes in lymphocytes - TarBase | ||||
miR-targeted genes in leukocytes - TarBase | ||||
Apoptosis Modulation and Signaling |
References | Top | |||
---|---|---|---|---|
REF 1 | Mcl-1 inhibitors: a patent review.Expert Opin Ther Pat. 2017 Feb;27(2):163-178. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.